Skip to content
HomeLatest newsCaring & giving12 reasons why you should give blood this summer
FINAL LEDE- 12 Reasons Why You Should Give Blood This Summer- Blood Donor hands

12 reasons why you should give blood this summer

Here’s a look at why the warm weather months are a crucial time to consider donating blood—and how just a few teaspoons can have a big impact on someone’s life.

Share Article
share to

Barbecues, beach time ... and blood donations?

You heard right. Summer is a key time to consider giving blood because blood banks across the country tend to experience a drastic decline in donations when it gets hot, thanks to vacation schedules and the fact that many blood drives take place at schools that are closed for the summer break.

That’s why donating right now is so important—and why Johnson & Johnson has made it a mission to help boost awareness of the need to give blood this time of year.

In fact, in 1947, Johnson & Johnson helped set up the first blood bank for hospitals in New Brunswick, New Jersey. The company provided refrigerators to store the donations, and employees gave blood to help establish the initial supply. In 1954, the company established a formal employee blood donor program, which evolved into the program that’s in place today.

Ever wonder how much of an impact a single donation could really make? We break it down—drop by drop.

12 Reasons Why You Should Give Blood This Summer: Blood Donation Facts, Statistics, and More

More from Johnson & Johnson

What to know about We All Belong: 2023 DEI Impact Review

The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.

Giving the gift of sight

In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.

Inside the development of a revolutionary treatment for blood cancers

In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.